© 2025 Institute for Biotechnology and Medicine Industry & Research Center for Biotechnology and Medicine Policy
ABLE COO Visits Healthcare+ Expo Taiwan, Opens Opportunities for Bio-AI Partnerships to Strengthen India’s Rural Healthcare
2025-07-10
📣Unlock New BioTech & MedTech Partnerships in Asia!
【2025 Registration Opens Now ▸ https://ibmi.pse.is/7mn2dd 】
As the global healthcare industry embraces an AI revolution, India is rapidly advancing its digital health transformation. According to Forbes, the National Institution for Transforming India (NITI Aayog) has identified artificial intelligence as a critical solution to bridge the rural healthcare workforce gap. Amid this sweeping change, Dr. Narayanan Suresh, COO of the Association of Biotechnology Led Enterprises (India), noted Taiwan’s strength in high-end medical solutions and agile healthcare innovation, calling it an ideal partner for India. To explore collaboration, he visited the 2024 Healthcare+ Expo Taiwan and engaged in business matchmaking events to look for strategic partners.
Dr. Narayanan Suresh, COO of the Association of Biotechnology Led Enterprises (India), highlighted the promising collaboration between India and Taiwan at the 2024 Healthcare+ Expo Taiwan, focusing on advancements in digital healthcare to bridge the rural healthcare divide.
Taiwan Firms Eye Entry into India’s Newly Opened Medtech Market
During the Expo, Suresh emphasized the vast potential of India’s medical device market, currently valued at around USD 12 billion. Notably, over 80% of the devices are still imported, indicating that local manufacturing capabilities are still developing. For Taiwanese companies with established strengths in high-end medical equipment, precision manufacturing, and innovative product design, this represents a golden window for market entry.
Up to 40% Government Subsidies: India Woos Investors, Taiwan Firms Strategize Expansion
To attract foreign investment in local manufacturing, the Indian government has launched the Production Linked Incentive (PLI) scheme, offering annual cost subsidies of up to 30–40% for foreign companies setting up plants in India. In tandem, the country’s expansive public and private healthcare systems and fast-growing urban population are driving demand for quality medical devices and smart diagnostics solutions.
For Taiwanese enterprises, this incentive significantly lowers initial setup costs and opens access to India’s broad industrial ecosystem. It’s not only just an export opportunity, but also the start of long-term overseas market cultivation.
Taiwanese C-level executives and Dr. Narayan Suresh engaged in discussions, exploring opportunities for partnerships and market expansion.
India Set to Become World’s Third Largest Economy—Medical Demand Keeps Rising
India’s GDP is expected to surpass Japan’s in 2025, becoming the world’s fourth largest economy, and is forecasted to reach third place by 2030. With this economic growth and infrastructure expansion, India is fast emerging as Asia’s next hotspot for healthcare investment.
Moreover, the Indian government is actively fostering biomedical clusters and improving industrial policies and infrastructure, creating a more favorable environment for investment from global players, including Taiwan.
Beyond investment and technological collaboration, ABLE also plays a vital role in helping foreign enterprises navigate India’s regulatory landscape. Through this Taiwan visit, Suresh not only presented India’s booming medical AI ambitions but also sought to establish direct dialogue with Taiwan’s medtech sector—aiming to forge stronger bilateral ties and unlock mutual growth in the medical industry.